CD8A and myeloid sarcoma: The IL18-driven activation, and the consequent CNS infiltration of CD8+ MAIT cells in MS, may cause reduced frequency in blood, helping to reconcile, at least in part, the conflicting results on the frequency of circulating MAIT cells in MS.